advisorsecurities master

INBXInhibrx Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
17067
Ticker
INBX
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2024-05-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
INBX

Detail

Enriched 2026-08-14 20:47

Market cap
$1,443,057,854.96
Shares outstanding (class)
14,671,186
Shares outstanding (weighted)
14,671,186
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
110
Location
LA JOLLA, CA
Description

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data